TailorMed

TailorMed

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.tailormed.co

Last Round

Early Funding

Nov 21, 2024

Total Funding Raised

$102.5M

Company Overview

TailorMed (Enterprise Systems) is a healthcare technology company that offers a medical financial management platform designed to assist chronically ill patients in optimizing their finances by identifying financial risks, matching them with personalized funding opportunities, and managing enrollment in relevant programs.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, Workflow Automation, Healthcare Analytics, Patient Engagement

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

financial navigation platformpatient financial assistancehealthcare affordabilityrevenue cycle managementRCMpatient accessfinancial toxicityco-pay assistancepatient assistance programsPAPsbad debt reductionmedication accesshealthcare SaaStech-enabled servicesEMR integrationspecialty pharmacy solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TailorMed Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TailorMed Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 21, 2024
Series CNov 21, 2024
Series BSep 29, 2021
Series AJun 20, 2019

Key People

Founding team and executive leadership

Adam Siton

Co-Founder, CTO

Founding Team

Israel Dvorsky

CEO, Co-founder

Founding Team

Gideon Jagermann

Chief Operating Officer - WE ARE HIRING

Executive Team

TailorMed Investors

Notable investors and investment history

InvestorRounds
Citi Impact FundSeries B, Series C
BrightEdgeSeries B, Series C
UnityPoint Health VenturesSeries B, Series C, Early Funding
OSF VenturesSeries B
Sanara VenturesSeries B, Series A, Series C, Seed, Early Funding
Allumia VenturesSeries C, Series B
Samsung NEXT VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Supported over 75 million patients since 2020.

  • Apr 7, 2026

    Reached over 945 hospitals, 4,700 clinics, and 3,100 pharmacies.

TailorMed Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TailorMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TailorMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range191
Year Founded2016
Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.